Document Detail


Long-term Outcomes of Pandemic 2009 Influenza A(H1N1)-Associated Severe ARDS.
MedLine Citation:
PMID:  23026856     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: No data on long-term outcomes of survivors of 2009 influenza A(H1N1) (A[H1N1])-associated ARDS are available. The objective of this study was to compare the 1-year outcomes of survivors of A(H1N1)-associated ARDS, according to use or no use of extracorporeal lung assist (ECLA), using its need as an ARDS severity surrogate. METHODS: Survivors of ARDS (12 with ECLA use vs 25 without, corresponding to 75% and 54% of the eligible patients for each group, respectively) selected from the Réseau Européen de Ventilation Artificielle (REVA) registry had previously been healthy, with only pregnancy and/or moderate obesity (BMI ≤ 35 kg/m2) as known risk factors for A(H1N1) infection. Lung function and morphology, health-related quality of life (HRQoL), and psychologic impairment were evaluated. RESULTS: At 1 year post-ICU discharge for the ECLA and no-ECLA groups, respectively, 50% and 40% reported significant exertion dyspnea, 83% and 64% had returned to work, and 75% and 64% had decreased diffusion capacity across the blood-gas barrier, despite their near-normal and similar lung function test results. For both groups, exercise test results showed diminished but comparable exercise capacities, with similar alveolar-arterial oxygen gradients at peak exercise, and CT scans showed minor abnormal findings. HRQoL assessed by the 36-Item Short-Form Health Survey was poorer for both groups than for a sex- and age-matched general population group, but without between-group differences. ECLA and no-ECLA group patients, respectively, had symptoms of anxiety (50% and 56%) and depression (28% and 28%) and were at risk for posttraumatic stress disorder (41% and 44%). CONCLUSIONS: One year post-ICU discharge, a majority of survivors of A(H1N1)-associated ARDS had minor lung disabilities with diminished diffusion capacities across the blood-gas barrier, and most had psychologic impairment and poorer HRQoL than a sex- and age-matched general population group. ECLA and no-ECLA group patients had comparable outcomes. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01271842; URL: www.clinicaltrials.gov.
Authors:
Charles-Edouard Luyt; Alain Combes; Marie-Hélène Becquemin; Catherine Beigelman-Aubry; Stéphane Hatem; Anne-Laure Brun; Nizar Zraik; Fabrice Carrat; Philippe A Grenier; Jean-Christophe M Richard; Alain Mercat; Laurent Brochard; Christian Brun-Buisson;
Related Documents :
7730526 - Assessing diagnostic approaches to depression in medically ill older adults: how reliab...
14987316 - Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?
12296676 - Validity and reliability of the short form-36 in cervical spondylotic myelopathy.
8675936 - Cross-validation of the delirium rating scale in older patients.
20195906 - Restless legs syndrome and its relationship with anxiety, depression, and quality of li...
19351236 - Efficacy and safety of intranasal xylometazoline and ipratropium in patients with commo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-1
Journal Detail:
Title:  Chest     Volume:  -     ISSN:  1931-3543     ISO Abbreviation:  Chest     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  -    
Other Details:
Languages:  ENG     Pagination:  583-592     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visual test of subparts per billion-level copper(ii) by Fe(3)O(4) magnetic nanoparticle-based solid ...
Next Document:  The genetics of scleroderma: looking into the postgenomic era.